Pharmaceutical Microbiology Market - Top Companies and Manufacturers

  • Report ID: 5870
  • Published Date: May 09, 2024
  • Report Format: PDF, PPT

Companies Dominating the Pharmaceutical Microbiology Landscape

    • NEOGEN Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Hardy Diagnostics
    • IDEXX
    • Charles River Laboratories
    • BioMerieux SA
    • Merck KGAA
    • Rapid Micro Biosystems.
    • Abbott Laboratories, Inc
    • Bio-Rad Laboratories
    • Gen-Probe, Inc

Browse Key Market Insights with Data Illustration:

In the News

  • NEOGEN Corporation unveiled Soleris® Next Generation (NG). The novel Soleris® Next Generation (NG) from NEOGEN is capable of quickly identifying a broad range of bacteria that may jeopardize the quality and safety of food and other consumer goods. For instance, whereas traditional methods require three to five days to identify and count yeast and mold in a sample, Solaris NG can do so in just 48 hours. Additionally, it can identify Alicyclobacillus, a bacterium of special concern to the fruit juice industry, in just 48 hours as opposed to five days using other methods.
  • Hardyc Diagnostics designed CmpactDry TCR, a ready-to-use dehydrated culture medium plate to identify and count microorganisms. It can yield total aerobic plate counts in as little as 24 hours. Being AOAC PTM (Association of Official Analytical Chemists - Performance Tested Methods) approved, this self-diffusing plate is the simplest to use for plate counts since it doesn't require spreading or stamping. Just take off the lid, pour 1 milliliter of sample onto the middle of the plate, replace the lid, and let it incubate.

Author Credits:  Radhika Pawar


  • Report ID: 5870
  • Published Date: May 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing investment in the healthcare infrastructure, rising demand for sterility of the products, and growing technological advancements are the major factors driving the growth of the pharmaceutical microbiology market.

The market size of pharmaceutical microbiology is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2024-2036.

The major players in the market are NEOGEN Corporation, Hardy Diagnostics, IDEXX, Charles River Laboratories, BioMerieux SA, Merck KGAA, Rapid Micro Biosystems., Abbott Laboratories, Inc., Bio-Rad Laboratories, Gen-Probe, Inc., and others.

The biopharmaceutical segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample